Sabrina Giometto
Pisa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Possible underdiagnosis of ulcerative colitis in tertiary care can affect medication use and access to healthcare facilities.
Journal: Frontiers in immunology
Published: August 27, 2025
Time Windows Used When Identifying Current Drug Use and Polypharmacy.
Journal: Pharmacoepidemiology and drug safety
Published: June 05, 2025
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed Database.
Journal: Pharmacoepidemiology and drug safety
Published: December 20, 2024
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project.
Journal: Expert opinion on biological therapy
Published: December 13, 2024
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use.
Journal: European journal of gastroenterology & hepatology
Published: September 19, 2023
Efficacy and safety of DAA in children and adolescents with chronic HCV infection: A systematic review and meta-analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: July 17, 2023
What Italian PICU Healthcare Providers Think About Donation After Cardiocirculatory Determination of Death: A National Survey.
Journal: Pediatric transplantation
Published: June 27, 2023
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.
Journal: Frontiers in pharmacology
Published: June 22, 2023
Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions-The CAESAR study.
Journal: Pharmacoepidemiology and drug safety
Published: June 12, 2023
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 23, 2023
A registry for Dravet syndrome: The Italian experience.
Journal: Epilepsia open
Published: August 15, 2022
Last Updated: 09/26/2026